Fertility warning
This medicine may affect fertility.
Leaflet VINORELBINA ACCORD 30mg soft capsules
- Product code:
- W69422001
- Quantity:
- 1
- Indicated for:
- cancer
- Route of administration:
- oral
- Substance:
- vinorelbine (antineoplastic agent)
- ATC
- L01CA04 — Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Vinca alkaloids and analogues
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Vinorelbine is a chemotherapy medication used for the treatment of various types of cancer, including non-small cell lung cancer and advanced breast cancer. It belongs to the vinca alkaloid class and works by inhibiting tubulin polymerization, which leads to the arrest of cell division and ultimately tumor cell death.
Vinorelbine is administered intravenously or orally, depending on the type and stage of cancer, and the dosage is adjusted based on body weight and patient response. Treatment is usually given in cycles to allow the body to recover between doses.
Common side effects include nausea, vomiting, fatigue, alopecia, and myelosuppression (reduction in blood cell counts). In rare cases, severe adverse reactions such as peripheral neuropathy or liver function impairment may occur.
Patients receiving vinorelbine should be regularly monitored for hematologic function and signs of toxicity. The medication is an important option in cancer treatment, helping to reduce tumor size and prolong patient survival.
Vinorelbine is administered intravenously or orally, depending on the type and stage of cancer, and the dosage is adjusted based on body weight and patient response. Treatment is usually given in cycles to allow the body to recover between doses.
Common side effects include nausea, vomiting, fatigue, alopecia, and myelosuppression (reduction in blood cell counts). In rare cases, severe adverse reactions such as peripheral neuropathy or liver function impairment may occur.
Patients receiving vinorelbine should be regularly monitored for hematologic function and signs of toxicity. The medication is an important option in cancer treatment, helping to reduce tumor size and prolong patient survival.
General data about VINORELBINA ACCORD 30mg
- Substance:
- vinorelbine
- Date of latest medicines list:
- 01-04-2023
- Product code:
- W69422001
- Concentration:
- 30mg
- Pharmaceutical form:
- soft capsules
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for vinorelbine
Concentrations available for vinorelbine
- 10mg/ml
- 20mg
- 30mg
- 50mg/5ml
- 80mg